Items Tagged ‘peripheral T-cell lymphoma’

August 16th, 2016

Opdivo® Highly Effective for Some Patients with Lymphomas

By

The immunotherapeutic agent, Opdivo® (nivolumab), appears to provide long-lasting anti-cancer activity among some patients who have received extensive prior therapy for both B- and T-cell lymphomas. These results were recently published in the Journal of Clinical Oncology. Lymphomas are a type of cancer that arise in immune cells. There are two main types of immune […]

View full entry

Tags: diffuse large B-cell lymphoma, Follicular Lymphoma, Lymphoma, News, nivolumab, Non-Hodgkin's Lymphoma, opdivo, peripheral T-cell lymphoma, T-Cell Non-Hodgkin's Lymphoma


March 16th, 2015

Beleodaq®

By

Class: Biological Therapy Generic Name: belinostat Trade Name: Beleodaq® For which conditions is this drug approved? Beleodaq is approved for the treatment of peripheral T-cell lymphoma (PTCL) that comes back or does not respond to treatment. What is the mechanism of action? Beleodaq is an agent known as a histone deacetylase inhibitor. It works by […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary, peripheral T-cell lymphoma


March 16th, 2015

belinostat

By

Class: Biological Therapy Generic Name: belinostat Trade Name: Beleodaq® For which conditions is this drug approved? Beleodaq is approved for the treatment of peripheral T-cell lymphoma (PTCL) that comes back or does not respond to treatment. What is the mechanism of action? Beleodaq is an agent known as a histone deacetylase inhibitor. It works by […]

View full entry

Tags: B, Biological Therapy, Drug Dictionary, peripheral T-cell lymphoma